ClusterOS Diagnostic Profile

Tel Aviv Life Sciences & BioTech

Tel Aviv, Israel Mature University anchor 63 evidence items

Tel Aviv Life Sciences & BioTech exhibits 8 observable stalls with Coordinating instead of deciding and Stabilizing around incumbents as primary behavioural patterns. 3 stabilisation stacks identified.

8
Active stalls
3
Stacks identified
63
Evidence items
6
Leverage timeline (mo)
S1
Re-proving instead of narrowing
low
S2
Coordinating instead of deciding
medium
S4
Extracting without reinvesting
low
S5
Mediating instead of coupling
low
S6
Stabilizing around incumbents
medium
S7
Narrating instead of testing
low
S8
Scaling activity instead of throughput
low
S9
Waiting for permission
low
Stack 01 S1 · S5 · S8

Re-proving (repeated establishment of accelerator/incubator programs 1991-2019) plausibly sustains Mediating (technology transfer offices, investment platforms creating intermediation infrastructure 1959-2017), which plausibly sustains Scaling activity (proliferation of research centers and training programs 1998-2024). Each new program/unit creates demand for intermediation;...

Stack 02 S6 · S2

Stabilising (continuity of universities established 1934-2011, medical centers >1,000 beds, Teva operations 1901-2024) plausibly sustains Coordinating (collaborative partnerships 2024, cross-domain infrastructure). Incumbent institutions possess network position and regulatory relationships that make coordination necessary for new initiatives; coordination activities reinforce...

Stack 03 S7 · S9

Narrating (policy/funding body establishment 2013-2021, Ministry divisions 2022-2023) plausibly sustains Waiting (same governance structure formation). Governance structure creation generates reporting and strategy functions (narrative activity) while simultaneously creating formal approval pathways; narrative production justifies governance expansion; governance expansion...

"If technology transfer offices were required to publish time-to-transaction metrics (application to license/spinout) for a subset of domains, it might reduce the system's ability to absorb uncertainty through pathway proliferation without exposing differential performance across intermediation...

6-12 months

Leverage hypotheses are testable perturbations, not prescriptions. Where demand-side behaviour is weakly visible, the correct move is observation — improving visibility before attempting change.

What happens next
This is a structural profile, not a full diagnostic.

A full ClusterOS diagnostic adds actor questionnaire data, working sessions, and anchor interviews — producing higher-confidence stall identification, board-ready stack analysis, and leverage hypotheses calibrated to your specific context.

Tel Aviv Life Sciences & BioTech
Diagnose your ecosystem →